Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 77

1.

Changes in levels of cortical metabotropic glutamate 2 receptors with gender and suicide but not psychiatric diagnoses.

Dean B, Duncan C, Gibbons A.

J Affect Disord. 2019 Feb 1;244:80-84. doi: 10.1016/j.jad.2018.10.088. Epub 2018 Oct 6.

PMID:
30326345
2.

Genome-Wide Supported Risk Variants in MIR137, CACNA1C, CSMD1, DRD2, and GRM3 Contribute to Schizophrenia Susceptibility in Pakistani Population.

Fatima A, Farooq M, Abdullah U, Tariq M, Mustafa T, Iqbal M, Tommerup N, Mahmood Baig S.

Psychiatry Investig. 2017 Sep;14(5):687-692. doi: 10.4306/pi.2017.14.5.687. Epub 2017 Sep 11.

3.

Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk.

Saini SM, Mancuso SG, Mostaid MS, Liu C, Pantelis C, Everall IP, Bousman CA.

Transl Psychiatry. 2017 Aug 8;7(8):e1196. doi: 10.1038/tp.2017.172.

4.

Risk-Conferring Glutamatergic Genes and Brain Glutamate Plus Glutamine in Schizophrenia.

Bustillo JR, Patel V, Jones T, Jung R, Payaknait N, Qualls C, Canive JM, Liu J, Perrone-Bizzozero NI, Calhoun VD, Turner JA, Gasparovic C.

Front Psychiatry. 2017 Jun 12;8:79. doi: 10.3389/fpsyt.2017.00079. eCollection 2017.

5.

A group II metabotropic glutamate receptor 3 (mGlu3, GRM3) isoform implicated in schizophrenia interacts with canonical mGlu3 and reduces ligand binding.

García-Bea A, Bermudez I, Harrison PJ, Lane TA.

J Psychopharmacol. 2017 Dec;31(12):1519-1526. doi: 10.1177/0269881117715597. Epub 2017 Jun 28.

6.

mGluR2 versus mGluR3 Metabotropic Glutamate Receptors in Primate Dorsolateral Prefrontal Cortex: Postsynaptic mGluR3 Strengthen Working Memory Networks.

Jin LE, Wang M, Galvin VC, Lightbourne TC, Conn PJ, Arnsten AFT, Paspalas CD.

Cereb Cortex. 2018 Mar 1;28(3):974-987. doi: 10.1093/cercor/bhx005.

PMID:
28108498
7.

Altered cortical processing of motor inhibition in schizophrenia.

Lindberg PG, Térémetz M, Charron S, Kebir O, Saby A, Bendjemaa N, Lion S, Crépon B, Gaillard R, Oppenheim C, Krebs MO, Amado I.

Cortex. 2016 Dec;85:1-12. doi: 10.1016/j.cortex.2016.09.019. Epub 2016 Sep 30.

PMID:
27770667
8.

The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia.

Maj C, Minelli A, Giacopuzzi E, Sacchetti E, Gennarelli M.

Curr Neuropharmacol. 2016;14(5):540-50. Review.

9.

Metabotropic glutamate receptor 3 (mGlu3; mGluR3; GRM3) in schizophrenia: Antibody characterisation and a semi-quantitative western blot study.

García-Bea A, Walker MA, Hyde TM, Kleinman JE, Harrison PJ, Lane TA.

Schizophr Res. 2016 Nov;177(1-3):18-27. doi: 10.1016/j.schres.2016.04.015. Epub 2016 Apr 27.

10.

Evaluation of relationship between GRM3 polymorphisms and cognitive function in schizophrenia of Han Chinese.

Chang M, Sun L, Liu X, Sun W, Ji M, Wang Z, Wang Y, You X.

Psychiatry Res. 2015 Oct 30;229(3):1043-6. doi: 10.1016/j.psychres.2015.06.012. Epub 2015 Jun 25.

PMID:
26187343
11.

Deletion of Metabotropic Glutamate Receptors 2 and 3 (mGlu2 & mGlu3) in Mice Disrupts Sleep and Wheel-Running Activity, and Increases the Sensitivity of the Circadian System to Light.

Pritchett D, Jagannath A, Brown LA, Tam SK, Hasan S, Gatti S, Harrison PJ, Bannerman DM, Foster RG, Peirson SN.

PLoS One. 2015 May 7;10(5):e0125523. doi: 10.1371/journal.pone.0125523. eCollection 2015.

12.

Effect of metabotropic glutamate receptor-3 variants on prefrontal brain activity in schizophrenia: An imaging genetics study using multi-channel near-infrared spectroscopy.

Kinoshita A, Takizawa R, Koike S, Satomura Y, Kawasaki S, Kawakubo Y, Marumo K, Tochigi M, Sasaki T, Nishimura Y, Kasai K.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Oct 1;62:14-21. doi: 10.1016/j.pnpbp.2015.04.006. Epub 2015 Apr 23.

PMID:
25914064
13.

Association of metabotropic glutamate receptor 3 gene polymorphisms with schizophrenia risk: evidence from a meta-analysis.

Yang X, Wang G, Wang Y, Yue X.

Neuropsychiatr Dis Treat. 2015 Mar 25;11:823-33. doi: 10.2147/NDT.S77966. eCollection 2015.

14.

Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction.

Walker AG, Wenthur CJ, Xiang Z, Rook JM, Emmitte KA, Niswender CM, Lindsley CW, Conn PJ.

Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1196-201. doi: 10.1073/pnas.1416196112. Epub 2015 Jan 12.

15.

Addiction and reward-related genes show altered expression in the postpartum nucleus accumbens.

Zhao C, Eisinger BE, Driessen TM, Gammie SC.

Front Behav Neurosci. 2014 Nov 5;8:388. doi: 10.3389/fnbeh.2014.00388. eCollection 2014.

16.

Synergistic association of PI4KA and GRM3 genetic polymorphisms with poor antipsychotic response in south Indian schizophrenia patients with low severity of illness.

Kaur H, Jajodia A, Grover S, Baghel R, Jain S, Kukreti R.

Am J Med Genet B Neuropsychiatr Genet. 2014 Dec;165B(8):635-46. doi: 10.1002/ajmg.b.32268. Epub 2014 Sep 11.

PMID:
25209194
17.

Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment.

Muguruza C, Miranda-Azpiazu P, Díez-Alarcia R, Morentin B, González-Maeso J, Callado LF, Meana JJ.

Neuropharmacology. 2014 Nov;86:311-8. doi: 10.1016/j.neuropharm.2014.08.009. Epub 2014 Aug 20.

PMID:
25150943
18.

Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia.

Bishop JR, Reilly JL, Harris MS, Patel SR, Kittles R, Badner JA, Prasad KM, Nimgaonkar VL, Keshavan MS, Sweeney JA.

Psychopharmacology (Berl). 2015 Jan;232(1):145-54. doi: 10.1007/s00213-014-3649-4. Epub 2014 Aug 7.

19.

The functional GRM3 Kozak sequence variant rs148754219 affects the risk of schizophrenia and alcohol dependence as well as bipolar disorder.

O'Brien NL, Way MJ, Kandaswamy R, Fiorentino A, Sharp SI, Quadri G, Alex J, Anjorin A, Ball D, Cherian R, Dar K, Gormez A, Guerrini I, Heydtmann M, Hillman A, Lankappa S, Lydall G, O'Kane A, Patel S, Quested D, Smith I, Thomson AD, Bass NJ, Morgan MY, Curtis D, McQuillin A.

Psychiatr Genet. 2014 Dec;24(6):277-8. doi: 10.1097/YPG.0000000000000050. No abstract available.

20.

Genetic risk prediction and neurobiological understanding of alcoholism.

Levey DF, Le-Niculescu H, Frank J, Ayalew M, Jain N, Kirlin B, Learman R, Winiger E, Rodd Z, Shekhar A, Schork N, Kiefer F, Wodarz N, Müller-Myhsok B, Dahmen N; GESGA Consortium, Nöthen M, Sherva R, Farrer L, Smith AH, Kranzler HR, Rietschel M, Gelernter J, Niculescu AB.

Transl Psychiatry. 2014 May 20;4:e391. doi: 10.1038/tp.2014.29. Erratum in: Transl Psychiatry. 2014;4:e456. Kiefe, F [corrected to Kiefer, F].

Supplemental Content

Loading ...
Support Center